About 80 percent of women who took metformin while following a modified carbohydrate diet lost about 10 percent of their body weight within a year, a New York Medical College study found.
一项纽约医科大学的研究结果显示，服用二甲双胍，并改变饮食中碳水化合物含量的女士中大概有百分之八十在一年内减掉了百分之十的体重。
Every single study has shown that metformin lowers blood sugar and all kinds of other things that are of value.
所有的研究都显示二甲双胍可以降低血糖，改善相关的指标。
Scientists hope that the metformin-chemo combination will result in a need for less chemo, thereby reducing painful side effects.
科学家希望二甲双胍-化疗药物联合用药能够减低化疗药物的剂量，从而减轻化疗药物令人痛苦的副作用。
The study results suggest that, in patients with both advanced heart failure and diabetes, use of metformin is safe, and may be associated with better heart failure survival.
研究结果提示，同时患有晚期心衰和糖尿病的患者，使用二甲双胍是安全的，并且有可能获得更佳的心衰生存率。
Is there any evidence that there is anything superior to metformin?
那么是否有证据表明有其它药物优于二甲双胍？
Prof Weng: I will say that I believe metformin is still the first-line.
我认为二甲双胍仍然是一线治疗药物。
Prior studies showed a lower cancer risk in diabetics who took metformin.
之前的研究表明服用二甲双胍的糖尿病患者患癌率降低。
An oral medication, metformin is the most commonly prescribed drug for type 2 diabetes.
口服二甲双胍是2型糖尿病最常用的处方药物。
The effect of metformin in the treatment of obese females with amenorrhea was observed.
本研究观察二甲双胍对肥胖女性伴停经的治疗效果。
The biguanide metformin is one of the mostly used drugs for treatment of type 2 diabetes.
二甲双胍是一种胰岛素增敏剂，多年来被广泛应用于对2型糖尿病患者的降血糖治疗。
Objective To investigate the protection of metformin on kidney in non-diabetic hypertension elderly.
目的研究二甲双胍对老年非糖尿病性高血压肾脏的保护作用。
CONCLUSIONS These results suggest that metformin use may be associated with a reduced risk of cancer.
结论：这些结果显示，使用二甲双胍可能降低患癌症的风险。
Objective To compare the effect of glimepiride and metformin in the treatment of metabolic syndrom (MS).
目的比较格列美脲与二甲双胍对代谢综合征(MS)患者的治疗效果。
This result suggests that the bridging N atom of metformin be important for its antihyperglycemic effect.
说明桥基N对二甲双胍的降血糖作用具有重要意义。
We found that patients on insulin were twice as likely to develop colon carcinomas than those on metformin.
研究发现，选择胰岛素的患者，患结肠癌的风险是选择二甲双胍患者的2倍。
In the current study, metformin was shown to be safe, and may be associated with favorable clinical outcomes.
在目前这项研究中，二甲双胍被证明是安全的，同时可能与有益的临床终点相关。
Objective: To observe the efficacy of Diane-35 combined with metformin treat polycystic ovary syndrome (PCOS).
目的：观察达英- 35联合二甲双胍治疗多囊卵巢综合征(PCOS)的疗效。
Pioglitazone was tested in combination with a sulfonylurea, insulin, or metformin in 8 trials (8501 patients).
吡格列酮联用磺脲类、胰岛素或者二甲双胍用于8项试验(8501个病人)。
Objective: To detect the effect of metformin on the target organ damage of spontaneous hypertension rats (SHR).
前言：目的：观察二甲双胍对白发性高血压大白鼠(SHR)靶器官病变的影响。
It's also possible, however, that metformin is working more directly on the tumor process, the researchers said.
研究人员说，也有可能二甲双胍更直接作用于肿瘤发生过程。
With respect to renal impairment, overall we say that GLP-1 based therapy has the same indications as metformin.
肾功能损害方面，总体上讲，GLP - 1类药物与二甲双胍的适应症是相同的。
Synthesize triazine compounds from metformin which is the prime material. 7 triazine compounds have been synthesized.
同时研究合成三嗪类衍生物，以二甲双胍为起始原料，合成了7个三嗪类化合物。
Ovulation rate was 33.3%, 23.35% with orlistat and metformin group respectively, but were not statistically significant.
奥利司他和二甲双胍组的排卵率分别是33.3%和23.35%，但无统计学差异。
The American Diabetes Association already recommends metformin, which has been proven to lower the risk of heart disease.
美国糖尿病协会已经推荐了二甲双胍，该药已被证明可以降低心脏病的风险。
The need for reevaluation of thyroid function in these patients within 6–12 months after starting metformin is indicated.
这就提示我们对于此类病人在使用二甲双胍的前6-12个月要对其甲功进行复查。
ObjectiveTo investigate the possible mechanism of kidney tissue damage and protective effect of metformin in diabetic mouse.
探讨糖尿病鼠肾脏组织损伤的可能机制及二甲双胍的保护作用。
CONCLUSIONS -monotherapy with GLP-1 and metformin have equal effects on plasma glucose and additive effects upon combination.
结论：GLP - 1和二甲双胍单药治疗对血糖效果相同，联合治疗会产生叠加效果。
Objective to study on the factors involved in the release rate of metformin hydrochloride in vitro sustained-release tablets.
目的对盐酸二甲双胍缓释片体外释放度相关因素进行研究。
Objective to study on the factors involved in the release rate of metformin hydrochloride in vitro sustained-release tablets.
目的对盐酸二甲双胍缓释片体外释放度相关因素进行研究。
应用推荐